This contract involves the supply of antibodies under a framework agreement divided into three parts for the Łukasiewicz Research Network - PORT Polish Center for Technology Development. The contracting authority will place orders for the supply of antibodies necessary for research tasks funded by i
Contract awarded. Originally published 9 months ago.
Only 2 prior awards here — too little to read.
In healthcare medical, UKASIEWICZ RESEARCH NETWORK PORT POLISH CENTER FOR TECHNOLOGY DEVELOPMENT has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of antibodies based on a framework agreement divided into 7 parts for the Łukasiewicz Research Network - PORT Polish Center for Technology Development. The contracting authority will place orders for the supply of antibodies necessary for research tasks funded by it
This contract involves the supply of an advanced High-Resolution Respirometry System, complete with software, for the Astrocyte Biology Research Group. The aim is to enhance research capabilities in the field of astrocyte biology by providing state-of-the-art laboratory equipment. Suppliers are invi
This contract involves the supply of laboratory reagents and antibodies under a framework agreement, divided into two parts for the Łukasiewicz Research Network - PORT Polish Center for Technology Development. The contracting authority will place orders for the necessary reagents to support research
This contract involves the supply of a spectral cytometer along with necessary equipment. Detailed specifications and requirements for the goods are provided in Annex 2 of the procurement documents, which includes a description of the items and in Annex 3, which contains the draft contract. The Comm
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
The LGA is recruiting 2 Health Engagement Advisors at £700/day (up to 60 days) to support SEND improvement across councils and ICBs until March 2027, requiring senior strategic healthcare experience.
NHS Blood and Transplant seeks supplier feedback on platelet agitator and incubator equipment options to inform a future multi-lot procurement for new equipment supply and maintenance of existing systems across England.